What’s Next?
For anyone serious about answering the healthcare challenges of the future, ensuring access to affordable high quality biopharmaceuticals is an indispensable part of the answer. Sandoz is working intensively to help meet the ever growing demand for these cutting-edge medicines, with numerous projects that build on our pioneering efforts to date and on our unique expertise and experience.
Biosimilars still face a number of challenges across geographies, in particular:
- The uncertain regulatory and legal environment in many countries and regions
- Significant development investment requirements in terms of time, resources, and expertise
- The need to access cost efficient and high quality manufacturing capacity and expertise
- The complex commercial environment, with stakeholders including competitors, regulators, payors, physicians, pharmacists, and patient groups
- Powerful originator competition
The factors above mean that Sandoz may face only moderate competition from a handful of dedicated players, but the next biologics revolution is already well under way. We are committed to leading the way in years and decades to come, and to doing our bit to transform patient care in the 21st century…
